Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

8 Items

per page
  1. BAY 60-6583
    B5612 BAY 60-6583
    Target: Adenosine A2B Receptors
    Summary: Potent A2B receptor agonist
      ≥36.1 mg/mL
  2. Rimonabant
    B1429 Rimonabant
     3 Citation
    Target: CB1 Receptors|CB2 Receptors
    Summary: CB1 receptor antagonist
      ≥23.19 mg/mL
  3. Azilsartan
    B2210 Azilsartan
    Target: Angiotensin AT1 Receptors
    Summary: Potent angiotensin II type 1 (AT1) receptor inverse agonist
      insoluble in EtOH; insoluble in H2O; ≥16.95 mg/mL
  4. Perindopril
    B1214 Perindopril
    Target: Angiotensin-Converting Enzymes (ACEs)
    Summary: ACE inhibitor
      Soluble in DMSO
  5. CL 316243 disodium salt
    B6766 CL 316243 disodium salt
    Summary: murine-selective β3 adrenoceptor agonist
      <46.58 mg/mL
  6. Exendin-4
    A3408 Exendin-4
    Target: Glucagon-like peptide 1 (GLP-1) receptors
    Summary: GLP-1 activator
      ≥145 mg/mL
  7. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: Glucagon receptor/IGF-1R antagonist
      ≥24.05 mg/mL
  8. TUG-770
    A3895 TUG-770
    Target: Free Fatty Acid Receptors
    Summary: FFA1/GPR40 agonist
      insoluble in H2O; ≥11.85 mg/mL

8 Items

per page